151 related articles for article (PubMed ID: 38023434)
1. Short-term and long-term clinical outcomes of combined major vessel resection for hilar cholangiocarcinoma: a propensity score analysis.
Wang Y; Lu J
Ann Surg Treat Res; 2023 Nov; 105(5):319-332. PubMed ID: 38023434
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Efficacy and Safety Between Laparoscopic and Open Radical Resection for Hilar Cholangiocarcinoma-A Propensity Score-Matching Analysis.
He YG; Huang W; Ren Q; Li J; Yang FX; Deng CL; Li LQ; Peng XH; Tang YC; Zheng L; Huang XB; Li YM
Front Oncol; 2022; 12():1004974. PubMed ID: 36226051
[TBL] [Abstract][Full Text] [Related]
3. Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium.
Schimizzi GV; Jin LX; Davidson JT; Krasnick BA; Ethun CG; Pawlik TM; Poultsides G; Tran T; Idrees K; Isom CA; Weber SM; Salem A; Hawkins WG; Strasberg SM; Doyle MB; Chapman WC; Martin RCG; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Fields RC
HPB (Oxford); 2018 Apr; 20(4):332-339. PubMed ID: 29169904
[TBL] [Abstract][Full Text] [Related]
4. Left hepatectomy combined with hepatic artery resection for hilar cholangiocarcinoma: A retrospective cohort study.
Peng C; Li C; Wen T; Yan L; Li B
Int J Surg; 2016 Aug; 32():167-73. PubMed ID: 27344254
[TBL] [Abstract][Full Text] [Related]
5. Combined portal vein resection in the treatment of hilar cholangiocarcinoma: a systematic review and meta-analysis.
Chen W; Ke K; Chen YL
Eur J Surg Oncol; 2014 May; 40(5):489-495. PubMed ID: 24685155
[TBL] [Abstract][Full Text] [Related]
6. Combined Vascular Resection for Locally Advanced Perihilar Cholangiocarcinoma.
Mizuno T; Ebata T; Yokoyama Y; Igami T; Yamaguchi J; Onoe S; Watanabe N; Kamei Y; Nagino M
Ann Surg; 2022 Feb; 275(2):382-390. PubMed ID: 32976284
[TBL] [Abstract][Full Text] [Related]
7. Vascular reconstruction provides short-term and long-term survival benefits for patients with hilar cholangiocarcinoma: A retrospective, multicenter study.
Huang YX; Xu C; Zhang CC; Liu GY; Liu XC; Fan HN; Pan B; Li YC
Hepatobiliary Pancreat Dis Int; 2024 May; ():. PubMed ID: 38824095
[TBL] [Abstract][Full Text] [Related]
8. Combined portal vein resection for hilar cholangiocarcinoma.
Bai T; Chen J; Xie ZB; Ma L; Liu JJ; Zhu SL; Wu FX; Li LQ
Int J Clin Exp Med; 2015; 8(11):21044-52. PubMed ID: 26885035
[TBL] [Abstract][Full Text] [Related]
9. [Clinical application of combined hepatic artery resection and reconstruction in surgical treatment for hilar cholangiocarcinoma].
Dai HS; Bie P; Wang SG; He Y; Li DJ; Tian F; Zhao X; Chen ZY
Zhonghua Wai Ke Za Zhi; 2018 Jan; 56(1):41-46. PubMed ID: 29325352
[No Abstract] [Full Text] [Related]
10. Effects of portal vein resection and hepatic artery resection on long-term survival in Klatskin tumor: a meta-analysis.
Song Y; Zhang Y; Zhen Z; Huang Z
World J Surg Oncol; 2022 Jul; 20(1):230. PubMed ID: 35821140
[TBL] [Abstract][Full Text] [Related]
11. Effect evaluation of vascular resection for patients with hilar cholangiocarcinoma: original data and meta-analysis.
Yu W; Gu Z; Shi S; Shen N; Zhang Y
Cell Biochem Biophys; 2014 Jul; 69(3):509-16. PubMed ID: 24510536
[TBL] [Abstract][Full Text] [Related]
12. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching.
Noji T; Tsuchikawa T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Shichinohe T; Hirano S
J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):442-8. PubMed ID: 27207604
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
14. Effect of vascular resection for perihilar cholangiocarcinoma: a systematic review and meta-analysis.
Liu Y; Li G; Lu Z; Wang T; Yang Y; Wang X; Liu J
PeerJ; 2021; 9():e12184. PubMed ID: 34631316
[TBL] [Abstract][Full Text] [Related]
15. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
[TBL] [Abstract][Full Text] [Related]
16. Effect evaluation of vascular resection for patients with hilar cholangiocarcinoma: original data and meta-analysis.
Yu W; Shao M; Gu Z; Shi S; Shen N; Zhang Y
Hepatogastroenterology; 2014; 61(130):307-13. PubMed ID: 24901130
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of vascular resection associated with curative intent hepatectomy for intrahepatic cholangiocarcinoma.
Conci S; Viganò L; Ercolani G; Gonzalez E; Ruzzenente A; Isa G; Salaris C; Fontana A; Bagante F; Pedrazzani C; Campagnaro T; Iacono C; De Santibanes E; Pinna DA; Torzilli G; Guglielmi A
Eur J Surg Oncol; 2020 Sep; 46(9):1727-1733. PubMed ID: 32360063
[TBL] [Abstract][Full Text] [Related]
18. [The safety and efficacy of combined hepatic artery resection in treatment of hilar cholangiocarcinoma: a meta-analysis].
Chen HM; Fu ZH; Deng DF; Huang JZ; Zhang X; Xu ZQ; Wang YD
Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(4):286-292. PubMed ID: 33486939
[No Abstract] [Full Text] [Related]
19. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract][Full Text] [Related]
20. Postoperative morbidity adversely impacts oncological prognosis after curative resection for hilar cholangiocarcinoma.
Liu ZP; Chen WY; Zhang YQ; Jiang Y; Bai J; Pan Y; Zhong SY; Zhong YP; Chen ZY; Dai HS
World J Gastroenterol; 2022 Mar; 28(9):948-960. PubMed ID: 35317056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
